• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Intensive Care . Changing epidemiology of acute kidney injury in critically ill patients with COVID-19: a prospective cohort

tetano

Editor, Senior Moderator
Ann Intensive Care


. 2022 Dec 28;12(1):118.
doi: 10.1186/s13613-022-01094-6.
Changing epidemiology of acute kidney injury in critically ill patients with COVID-19: a prospective cohort


Nuttha Lumlertgul[SUP] 1 2 3 [/SUP], Eleanor Baker[SUP] 1 [/SUP], Emma Pearson[SUP] 1 [/SUP], Kathryn V Dalrymple[SUP] 4 [/SUP], Jacqueline Pan[SUP] 1 [/SUP], Anup Jheeta[SUP] 1 [/SUP], Kittisak Weerapolchai[SUP] 1 5 [/SUP], Yanzhong Wang[SUP] 4 [/SUP], Richard Leach[SUP] 1 [/SUP], Nicholas A Barrett[SUP] 1 [/SUP], Marlies Ostermann[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Acute kidney injury (AKI) is common in critically ill patients with coronavirus disease-19 (COVID-19). We aimed to explore the changes in AKI epidemiology between the first and the second COVID wave in the United Kingdom (UK).
Methods: This was an observational study of critically ill adult patients with COVID-19 in an expanded tertiary care intensive care unit (ICU) in London, UK. Baseline characteristics, organ support, COVID-19 treatments, and patient and kidney outcomes up to 90 days after discharge from hospital were compared.
Results: A total of 772 patients were included in the final analysis (68% male, mean age 56 ± 13.6). Compared with wave 1, patients in wave 2 were older, had higher body mass index and clinical frailty score, but lower baseline serum creatinine and C-reactive protein (CRP). The proportion of patients receiving invasive mechanical ventilation (MV) on ICU admission was lower in wave 2 (61% vs 80%; p < 0.001). AKI incidence within 14 days of ICU admission was 76% in wave 1 and 51% in wave 2 (p < 0.001); in wave 1, 32% received KRT compared with 13% in wave 2 (p < 0.001). Patients in wave 2 had significantly lower daily cumulative fluid balance (FB) than in wave 1. Fewer patients were dialysis dependent at 90 days in wave 2 (1% vs. 4%; p < 0.001).
Conclusions: In critically ill adult patients admitted to ICU with COVID-19, the risk of AKI and receipt of KRT significantly declined in the second wave. The trend was associated with less MV, lower PEEP and lower cumulative FB.
Trial registration: NCT04445259.

Keywords: Acute kidney injury; COVID-19; Critically ill; Kidney replacement therapy; Wave.
 
Back
Top Bottom